These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21921264)

  • 1. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.
    Tiburcy M; Didié M; Boy O; Christalla P; Döker S; Naito H; Karikkineth BC; El-Armouche A; Grimm M; Nose M; Eschenhagen T; Zieseniss A; Katschinksi DM; Hamdani N; Linke WA; Yin X; Mayr M; Zimmermann WH
    Circ Res; 2011 Oct; 109(10):1105-14. PubMed ID: 21921264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling myocardial growth and hypertrophy in engineered heart muscle.
    Tiburcy M; Zimmermann WH
    Trends Cardiovasc Med; 2014 Jan; 24(1):7-13. PubMed ID: 23953977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.
    Hirt MN; Boeddinghaus J; Mitchell A; Schaaf S; Börnchen C; Müller C; Schulz H; Hubner N; Stenzig J; Stoehr A; Neuber C; Eder A; Luther PK; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2014 Sep; 74():151-61. PubMed ID: 24852842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering an in vitro organotypic model for studying cardiac hypertrophy.
    Jain A; Hasan J; Desingu PA; Sundaresan NR; Chatterjee K
    Colloids Surf B Biointerfaces; 2018 May; 165():355-362. PubMed ID: 29518684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function.
    Jackman C; Li H; Bursac N
    Acta Biomater; 2018 Sep; 78():98-110. PubMed ID: 30086384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes.
    Sheehy SP; Grosberg A; Qin P; Behm DJ; Ferrier JP; Eagleson MA; Nesmith AP; Krull D; Falls JG; Campbell PH; McCain ML; Willette RN; Hu E; Parker KK
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1643-1656. PubMed ID: 28343439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGF-BB protects cardiomyocytes from apoptosis and improves contractile function of engineered heart tissue.
    Vantler M; Karikkineth BC; Naito H; Tiburcy M; Didié M; Nose M; Rosenkranz S; Zimmermann WH
    J Mol Cell Cardiol; 2010 Jun; 48(6):1316-23. PubMed ID: 20307544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for synergy between sarcomeres and fibroblasts in an in vitro model of myocardial reverse remodeling.
    Shen S; Sewanan LR; Campbell SG
    J Mol Cell Cardiol; 2021 Sep; 158():11-25. PubMed ID: 33992697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues.
    Leonard A; Bertero A; Powers JD; Beussman KM; Bhandari S; Regnier M; Murry CE; Sniadecki NJ
    J Mol Cell Cardiol; 2018 May; 118():147-158. PubMed ID: 29604261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro.
    Katare RG; Ando M; Kakinuma Y; Sato T
    PLoS One; 2010 Feb; 5(2):e9275. PubMed ID: 20174664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue engineering of a differentiated cardiac muscle construct.
    Zimmermann WH; Schneiderbanger K; Schubert P; Didié M; Münzel F; Heubach JF; Kostin S; Neuhuber WL; Eschenhagen T
    Circ Res; 2002 Feb; 90(2):223-30. PubMed ID: 11834716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decellularized extracellular matrix bioinks and the external stimuli to enhance cardiac tissue development in vitro.
    Das S; Kim SW; Choi YJ; Lee S; Lee SH; Kong JS; Park HJ; Cho DW; Jang J
    Acta Biomater; 2019 Sep; 95():188-200. PubMed ID: 30986526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.
    Hirt MN; Werner T; Indenbirken D; Alawi M; Demin P; Kunze AC; Stenzig J; Starbatty J; Hansen A; Fiedler J; Thum T; Eschenhagen T
    J Mol Cell Cardiol; 2015 Apr; 81():1-9. PubMed ID: 25633833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.
    Tiburcy M; Hudson JE; Balfanz P; Schlick S; Meyer T; Chang Liao ML; Levent E; Raad F; Zeidler S; Wingender E; Riegler J; Wang M; Gold JD; Kehat I; Wettwer E; Ravens U; Dierickx P; van Laake LW; Goumans MJ; Khadjeh S; Toischer K; Hasenfuss G; Couture LA; Unger A; Linke WA; Araki T; Neel B; Keller G; Gepstein L; Wu JC; Zimmermann WH
    Circulation; 2017 May; 135(19):1832-1847. PubMed ID: 28167635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue.
    Li Y; Asfour H; Bursac N
    Acta Biomater; 2017 Jun; 55():120-130. PubMed ID: 28455218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a biological ventricular assist device: preliminary data from a small animal model.
    Yildirim Y; Naito H; Didié M; Karikkineth BC; Biermann D; Eschenhagen T; Zimmermann WH
    Circulation; 2007 Sep; 116(11 Suppl):I16-23. PubMed ID: 17846298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes.
    Madsen A; Krause J; Höppner G; Hirt MN; Tan WLW; Lim I; Hansen A; Nikolaev VO; Foo RSY; Eschenhagen T; Stenzig J
    J Mol Cell Cardiol; 2021 May; 154():115-123. PubMed ID: 33582159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle.
    Naito H; Melnychenko I; Didié M; Schneiderbanger K; Schubert P; Rosenkranz S; Eschenhagen T; Zimmermann WH
    Circulation; 2006 Jul; 114(1 Suppl):I72-8. PubMed ID: 16820649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction.
    Porrello ER; Bell JR; Schertzer JD; Curl CL; McMullen JR; Mellor KM; Ritchie RH; Lynch GS; Harrap SB; Thomas WG; Delbridge LM
    Am J Physiol Regul Integr Comp Physiol; 2009 Mar; 296(3):R672-80. PubMed ID: 19129376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.